Camtek Ltd. - Ordinary Shares (CAMT)

Camtek Ltd. (NASDAQ: CAMT) reported record Q3 2025 revenue and strong operational execution, but one-time charges led to GAAP net loss.

Camtek posts record Q3 2025 earnings, meeting EPS estimates. Despite strong results, stock falls on revenue miss and guidance viewed as cautious.

Chip-gear supplier Camtek beat estimates for the third quarter but gave in-line guidance for the current period. Camtek stock fell.

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off

Camtek's (NYSE: CAMT) short interest as a percent of float has risen 19.74% since its last report. According to exchange reported data, there are now 4.49 million shares sold short, which is 15.95% of all regular shares that are available for trading.

NEW YORK – The financial markets are buzzing with optimistic forecasts as S&P 500 companies are projected to achieve a robust 15% increase in corporate earnings for Calendar Year (CY) 2025. This significant anticipated growth is serving as a powerful fundamental underpinning for current market performance, promising to extend a

Top-line growth in the company's current quarter is forecast to be lower than in the previous period.

Camtek reported mixed Q2 2025 earnings, missing revenue and EPS estimates slightly but delivering record results. The company provided optimistic Q3 guidance, projecting $125M revenue, aligning with analyst expectations. Shares rose modestly, reflecting investor confidence.

CAMT earnings call for the period ending December 31, 2024.

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.